Drug Profile
Research programme: therapies - Kirin/Nuvelo
Latest Information Update: 22 May 2006
Price :
$50
*
At a glance
- Originator Kirin Brewery; Nuvelo
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 31 Dec 2005 Discontinued - Preclinical for Undefined in Japan (unspecified route)
- 31 Dec 2005 Discontinued - Preclinical for Undefined in USA (unspecified route)
- 22 Sep 2004 Preclinical trials in Undefined in Japan (unspecified route)